0
Correspondence |

Association Between Angiotensin Receptor Blockers and Better Cognitive Outcome: Urgent Need for a Randomized Trial

Roxana Oprisiu, MD; Albert Fournier, MD; Jean Michel Achard, MD, PhD; Sandra E. Black, MD, FRCPC; Jean-Marie Serot, MD, PhD; Olivier Godefroy, MD, PhD
JAMA Neurol. 2013;70(3):413-414. doi:10.1001/jamaneurol.2013.1804.
Text Size: A A A
Published online

Extract

We are very interested in the autopsy study by Hajjar et al1: to our knowledge, it provides the first clinical translational evidence for an association between angiotensin receptor blockers (ARBs) and better cognitive performance, as well as reduced brain amyloid accumulation post mortem, when compared with hypertensive patients treated with other drugs or not treated at all.

These better results with ARB treatment compared with angiotensin-converting enzyme inhibitors (ACEIs) are compatible with data from transgenic mice showing that valsartan treatment enhances the expression of insulin-degrading enzyme, which also degrades amyloid peptides,2 whereas ACEIs increase amyloid pathology by blocking angiotensin-converting enzyme, which catabolizes toxic amyloid-β 42 into less toxic amyloid-β 40 peptides. Angiotensin receptor blockers also increase angiotensin II and IV, which have memory-protective effects by activation of angiotensin AT2 and AT4 receptors.3

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();